Association of a genetic variant in angiopoietin-like 3 with serum HDL-C and risk of cardiovascular disease: A study of the MASHAD cohort over 6 years
- PMID: 38634215
- PMCID: PMC11024632
- DOI: 10.1002/mgg3.2418
Association of a genetic variant in angiopoietin-like 3 with serum HDL-C and risk of cardiovascular disease: A study of the MASHAD cohort over 6 years
Abstract
Background: Loss-of-function (LOF) variants of the angiopoietin-like 3 (ANGPTL3) gene are reported to be associated with serum triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) concentrations and thereby affect the risk of cardiovascular disease (CVD).
Objective: In the present study, we examined the association of rs10789117 in the ANGPTL 3 gene locus and the risk of CVD in the group of people who were part of the Mashhad-Stroke and Heart-Atherosclerotic-Disorders (MASHAD) cohort.
Methods: One thousand and two healthy individuals enrolled in this study of whom 849 subjects were healthy and 153 subjects developed CVD outcomes after 6 years of follow-up. After a 12-h overnight fasting, 20 mL of blood samples were collected for the measurement of fasting blood glucose and lipid profile. DNA was extracted, and the Tetra-ARMS PCR (amplification refractory mutation system) was used for genotyping of rs10789117 in the ANGPTL3 gene. The genotype frequencies of the variant of rs10789117 in the ANGPTL3 gene were estimated using χ2 tests. Eventually, the statistical analysis was done by SPSS version 20.
Results: Individuals with AC/CC genotypes (rs10789117) were found to have to greater risk of CVD events compared to AA genotype (OR = 1.43, 95%CI = 1.01-2.02, p = 0.041). There was a 1.3-fold increase in cardiovascular events in individuals carrying the C allele of rs10789117 variant compared to non-carriers (OR = 1.32, 95%CI = 1.06-1.72, p value = 0.038). There were significant differences between different genotypes for serum triglyceride levels within the control group, but this difference was not significant in the group with CVD. Moreover, there was a significant association between CC genotype and CVD risk in the individuals with a normal serum HDL-C.
Conclusion: We have found that a rs10789117 C>A in ANGPTL3 gene polymorphism was associated with incident CVD events, and this may be of value as a risk stratification biomarker in CVD in the Iranian population.
Keywords: ANGPTL3; HDL‐C; cardiovascular disease; polymorphism.
© 2024 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Figures
Similar articles
-
The Association Between rs1748195 and rs11207997 Variants of the ANGPTL3 Gene and Susceptibility to Cardiovascular Disease in the MASHAD Cohort Study.Biochem Genet. 2022 Apr;60(2):738-754. doi: 10.1007/s10528-021-10122-2. Epub 2021 Aug 21. Biochem Genet. 2022. PMID: 34417926
-
Association of ANGPTL3 polymorphisms with high-density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease.J Clin Lab Anal. 2021 Dec;35(12):e23980. doi: 10.1002/jcla.23980. Epub 2021 Oct 24. J Clin Lab Anal. 2021. PMID: 34689370 Free PMC article.
-
A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia.Gene. 2021 May 25;782:145525. doi: 10.1016/j.gene.2021.145525. Epub 2021 Feb 23. Gene. 2021. PMID: 33636293
-
New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.Lipids Health Dis. 2018 Jan 15;17(1):12. doi: 10.1186/s12944-018-0659-y. Lipids Health Dis. 2018. PMID: 29334984 Free PMC article. Review.
-
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9. Nutr Metab Cardiovasc Dis. 2013. PMID: 23932901 Review.
References
-
- Aghasizadeh, M. , Nosrati, M. , Saberi‐Karimian, M. , Safarian, H. , Assadian, P. , Akbarpour, E. , Sahebkar, A. , Avan, A. , Ferns, G. A. , Kazemi, T. , Miri‐Moghaddam, E. , & Ghayour‐Mobarhan, M. (2021). Association of ANGPTL3 polymorphisms with high‐density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease. Journal of Clinical Laboratory Analysis, 35(12), e23980. - PMC - PubMed
-
- Aghasizadeh, M. , Zare‐Feyzabadi, R. , Kazemi, T. , Avan, A. , Ferns, G. A. , Esmaily, H. , Miri‐Moghaddam, E. , & Ghayour‐Mobarhan, M. (2021). A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia. Gene, 782, 145525. - PubMed
-
- Aim‐High Investigators . (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. New England Journal of Medicine, 365(24), 2255–2267. - PubMed
-
- Asselbergs, F. , Drenos, F. , Elbers, C. , Guo, Y. , van Iperen, E. P. , Keating, B. , Sivapalaratnam, S. , & Tragante, V. (2012). Twenty‐three unreported genetic associations with lipid phenotypes: A dense gene‐centric meta‐analysis in 66,240 individuals across 32 studies. AJHG.
-
- Brunham, L. R. , & Hayden, M. R. (2015). Human genetics of HDL: Insight into particle metabolism and function. Progress in Lipid Research, 58, 14–25. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous